Abstract
In epidemiological studies, childhood asthma is usually assessed with questionnaires directed at parents or children, and these may give different answers. We studied how well parents and children agreed when asked to report symptoms of wheeze and investigated whose answers were closer to measurable traits of asthma.
LuftiBus in the school is a cross-sectional survey of respiratory health among Swiss schoolchildren aged 6-17 years. We applied questionnaires to parents and children asking about wheeze and exertional wheeze in the past year. We assessed agreement between parent-child answers with Cohen’s kappa (k), and associations of answers from children and parents with physiological measurements (i.e. FeNO and FEV1/FVC), using quantile regression.
We received questionnaires from 3079 children and their parents. Agreement was poor for reported wheeze (k=0.37) and exertional wheeze (k=0.36). Median FeNO varied when wheeze was reported by children (19 ppb, IQR: 9-44), parents (22 ppb, IQR: 12-46), both (31 ppb, IQR: 16-55) or neither (11 ppb, IQR: 7-19). Median absolute FEV1/FVC was the same when wheeze was reported by children (84%, IQR: 78-89) and by parents (84%, IQR: 78-89), lower when reported by both (82%, IQR: 78-87) and higher when reported by neither (87%, IQR: 82-91). For exertional wheeze findings were similar. Results did not differ by age or sex.
Our findings suggest that surveying both parents and children and combining their responses can help us to better identify children with measurable asthma traits.
Take home message There is poor agreement between schoolchildren and their parents when reporting current wheeze. However, wheeze correlates best with lung function and FeNO when reported by both children and parents.
Competing Interest Statement
Dr. Moeller reports grants from Lunge Zuerich, personal fees from Vertex. Dr. Latzin reports personal fees from Gilead, Novartis, OM pharma, Polyphor, Roche, Santhera, Schwabe, Vertex, Vifor, Zambon and grants from Vertex. Dr. Usemann reports grants from Swiss lung foundation and Palatin foundation (Basel, Switzerland) and personal fees from Vertex and Aha Allergy Center Switzerland. Dr. Singer reports grants from Bern lung foundation, Swiss Cystic Fibrosis Society, Baetzebaer Stiftung KinderInsel Switzerland and personal fees from Vertex and Novartis.
Funding Statement
Lunge Zurich, Switzerland, funded the study set-up, development, and data collection with a grant to Alexander Moeller. Lunge Zurich and University Children's Hospital Zurich and Children's Research Center, University of Zurich, Switzerland, funds LUIS data management, data analysis and publications. Analysis has been supported by a grant of the Swiss National Science Foundation (320030_173044) to Claudia Kuehni. Myrofora Goutaki, Jakob Usemann and Florian Singer received grants from the Swiss National Science Foundation, the Swiss lung foundation, and the Bern lung foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the canton of Zurich approved the study (KEK-ZH-Nr: 2014-0491).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Study collaborators and other researchers can obtain datasets for analysis if a detailed concept sheet is presented for the planned analyses and approved by the principal investigators (AM, PL and CK).